etomoxir has been researched along with fumonisin b1 in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (fumonisin b1) | Trials (fumonisin b1) | Recent Studies (post-2010) (fumonisin b1) |
---|---|---|---|---|---|
260 | 8 | 93 | 1,484 | 14 | 454 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, MW; Baek, SH; Dan, JM; Kim, JE; Kim, JY; Kim, YW; Lee, IK; Park, SY | 1 |
1 other study(ies) available for etomoxir and fumonisin b1
Article | Year |
---|---|
AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblast.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antioxidants; Apoptosis; Butadienes; Caprylates; Cell Differentiation; Cell Line; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Fumonisins; Humans; Multienzyme Complexes; Nitriles; Osteoblasts; Palmitates; Protein Serine-Threonine Kinases; Ribonucleotides; Time Factors | 2008 |